Health In Tech (NASDAQ:HIT) Director Sells $10,920.00 in Stock

Health In Tech, Inc. (NASDAQ:HIT) Director Timothy Hayes sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $0.91, for a total transaction of $10,920.00. Following the completion of the transaction, the director owned 120,780 shares in the company, valued at approximately $109,909.80. This represents a 9.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Timothy Hayes also recently made the following trade(s):

• On Wednesday, September 9th, Timothy Hayes sold 5,730 shares of Health In Tech stock. The shares were sold at an average price of $0.93, for a total value of $5,328.90.

Health In Tech Price Performance

HIT opened at $0.91 on Monday. The company has a market capitalization of $59.36 million, a PE ratio of -12.94 and a beta of 2.72. The business has a 50-day moving average of $1.04 and a 200-day moving average of $1.24. Health In Tech, Inc. has a fifty-two week low of $0.85 and a fifty-two week high of $4.02.

Health In Tech (NASDAQ:HIT) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). The company had revenue of $8.06 million during the quarter.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. Maxim Group cut their price target on shares of Health In Tech from $4.00 to $3.00 and set a “buy” rating on the stock in a report on Friday, August 14th. Weiss Ratings reiterated a “sell (d)” rating on shares of Health In Tech in a report on Tuesday, June 30th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $3.50.

Hedge Funds Weigh In On Health In Tech

A number of institutional investors and hedge funds have recently bought and sold shares of HIT. Whetstone Capital Advisors LLC bought a new stake in Health In Tech in the 2nd quarter valued at $1,525,000. Millennium Management LLC acquired a new stake in Health In Tech in the 3rd quarter worth $85,000. Renaissance Technologies LLC acquired a new stake in Health In Tech in the 4th quarter worth $214,000. Two Sigma Investments LP bought a new position in shares of Health In Tech during the 3rd quarter worth about $386,000. Finally, Ancora Advisors LLC bought a new position in shares of Health In Tech during the 3rd quarter worth about $389,000.

About Health In Tech

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.